Saniona AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.04.20	Saniona appoints Rudolf Baumgartner, M.D., as Chief Medical Officer and Head of Clinical Development (GlobeNewswire)
22.04.20	Saniona Reports Positive Topline Results from Phase 2 Trial of Tesomet in Hypothalamic Obesity (GlobeNewswire)
15.04.20	Saniona publishes Its Annual Report for 2019 (GlobeNewswire)
03.04.20	Notice of annual shareholders’ meeting in Saniona AB (GlobeNewswire)
31.03.20	Saniona changes date for Annual General Meeting and updates financial calendar (GlobeNewswire)
26.03.20	Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia (GlobeNewswire)
24.03.20	Saniona Announces Management Transition to Support Strategic Transformation (GlobeNewswire)
18.03.20	Saniona completes its six months double blind Phase 2a trial of Tesomet in hypothalamic obesity (GlobeNewswire)
11.03.20	Saniona’s announces last day of trading in BTU and first day of trading in warrants of series TO 1, TO 2 and TO 3 (GlobeNewswire)
04.03.20	Saniona’s rights issue of free-of-payment units is oversubscribed (GlobeNewswire)
19.02.20	Saniona publishes supplementary prospectus (GlobeNewswire)
18.02.20	Saniona announces Chief Financial Officer Thomas Feldthus will be departing the company (GlobeNewswire)
18.02.20	Saniona co-founds new migraine therapy company Cephagenix (GlobeNewswire)
14.02.20	Correction regarding ISIN code for BTU in prospectus (GlobeNewswire)
14.02.20	Saniona publishes prospectus relating to the rights issue of units (GlobeNewswire)
07.02.20	Bulletin from the extraordinary general meeting on February 7, 2020 in Saniona AB (GlobeNewswire)
07.02.20	Saniona publishes its year-end report for 2019 (GlobeNewswire)
31.01.20	Change in number of shares and votes in Saniona AB (publ) (GlobeNewswire)
10.01.20	Notice of extraordinary general meeting in Saniona AB (GlobeNewswire)
10.01.20	Saniona completes private placement of SEK 25 million and proposes financing of up to SEK 158 million (GlobeNewswire)
07.01.20	Saniona appoints CNS & rare disease veteran Rami Levin as President and Chief Executive Officer (GlobeNewswire)
29.11.19	Change in number of shares and votes in Saniona AB (publ) (GlobeNewswire)
27.11.19	Saniona AB’s Nomination Committee for the Annual General Meeting 2020 (GlobeNewswire)
13.11.19	Saniona publishes its interim report for the third quarter 2019 (GlobeNewswire)
11.11.19	Saniona completes patient recruitment in Phase 2a hypothalamic obesity study (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Part Grp Hldg	1’261.50	2.73 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.40	2.01 %	K V
Geberit	524.60	1.55 %	K V
ABB	50.28	1.41 %	K V
Swiss Life Hldg	731.60	0.61 %	K V
UBS Group	28.29	0.53 %	K V
Kuehne+Nagel Int	208.70	0.34 %	K V
Nestle	76.18	0.29 %	K V
Swisscom	506.00	0.10 %	K V

Nachrichten zu Saniona AB

Aktien Top/Flop

Meistgelesene Nachrichten